Correlation of overall survival (OS) with bone marrow blast (BMBL) response in patients (pts) with myelodysplastic syndrome

被引：0
|
作者：
Silverman, Lewis R.
Fenaux, Pierre
Greenberg, Peter
Demakos, Erin P.
Santini, Valeria
Seymour, John Francis
Navada, Shyamala Chendal
Petrone, Michael E.
Snyder, Barbara R.
Azarnia, Nozar
Garcia-Manero, Guillermo
机构：
[1] Mt Sinai Med Ctr, New York, NY 10029 USA
[2] Hosp St Louis, Paris, France
[3] Stanford Univ, Stanford, CA 94305 USA
[4] Univ Florence, Azienda Osped Univ Careggi, Florence, Italy
[5] Peter MacCallum Canc Inst, Richmond, Vic, Australia
[6] Mt Sinai Hosp, New York, NY 10029 USA
[7] Onconova Therapeut Inc, Pennington, NJ USA
[8] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7017
引用
收藏
页数：1
相关论文
共 50 条
  • [1] CORRELATION OF OVERALL SURVIVAL (OS) WITH BONE MARROW BLAST (BMBL) RESPONSE IN PATIENTS (PTS) WITH MYELODYSPLASTIC SYNDROMES (MDS)
    Silverman, L.
    Fenaux, P.
    Greenberg, P.
    Demakos, E.
    Santini, V.
    Seymour, J.
    Navada, S.
    Petrone, M.
    Snyder, B.
    Azarnia, N.
    Garcia-Manero, G.
    HAEMATOLOGICA, 2015, 100 : 242 - 242
  • [2] Relationship of bone marrow blast (BMBL) response to overall survival (OS) in a multicenter study of rigosertib (Rigo) in patients (pts) with myelodysplastic syndrome (MDS) with excess blasts progressing on or after treatment with a hypomethylating agent (HMA)
    Al-Kali, Aref
    Hiwase, Devendra
    Baer, Maria R.
    Greenberg, Peter
    Shortt, Jake
    Collins, Robert
    Steensma, David P.
    Verma, Amit
    Roboz, Gail J.
    Shammo, Jamile M.
    Ottmann, Oliver G.
    Seymour, John Francis
    Szer, Jeffrey
    Meyer, Wolfgang
    Zbyszewski, Patrick Simon
    Petrone, Michael E.
    Fruchtman, Steven M.
    Garcia-Manero, Guillermo
    Silverman, Lewis R.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Relationship of Bone Marrow Blast (BMBL) Response to Overall Survival (OS) in Patients with Higher-Risk Myelodysplastic Syndrome (HR-MDS) Treated with Rigosertib after Failure of Hypomethylating Agents (HMAs)
    Silverman, Lewis R.
    Fenaux, Pierre
    Al-Kali, Aref
    Baer, Maria R.
    Sekeres, Mikkael A.
    Roboz, Gail J.
    Gaidano, Gianluca
    Scott, Bart L.
    Greenberg, Peter L.
    Platzbecker, Uwe
    Steensma, David P.
    Kambhampati, Suman
    Kreuzer, Karl-Anton
    Godley, Lucy A.
    Collins, Robert
    Atallah, Ehab
    Navada, Shyamala C.
    Wilhelm, Francois
    Azarnia, Nozar
    Garcia-Manero, Guillermo
    BLOOD, 2014, 124 (21)
  • [4] Overall Survival In Myelodysplastic Syndrome or Acute Myeloid Leukemia Patients Treated with On 01910.Na Correlates with Bone Marrow Blast Response.
    Silverman, Lewis R.
    Kaza, Azra
    Sloand, Elaine M.
    Greenberg, Peter L.
    Wilhelm, Frandois E.
    BLOOD, 2010, 116 (21) : 1629 - 1630
  • [5] BONE MARROW BLAST (BMBL) RESPONSE CORRELATES WITH OVERALL SURVIVAL IN RIGOSERTIB-TREATED PATIENTS WITH HIGHER-RISK MDS AFTER FAILURE OF HYPOMETHYLATING AGENTS (HMAS): A NEW RESPONSE CRITERION?
    Silverman, L. R.
    Fenaux, P.
    Al-Kali, A.
    Baer, M. R.
    Sekeres, M.
    Roboz, G.
    Gaidano, G.
    Scott, B.
    Greenberg, P.
    Platzbecker, U.
    Steensma, D. P.
    Kambhampati, S.
    Kreuzer, K. A.
    Godley, L.
    Collins, R.
    Atallah, E.
    Navada, S. C.
    Azarnia, N.
    Garcia-Manero, G.
    LEUKEMIA RESEARCH, 2015, 39 : S44 - S45
  • [6] Leukocyte Alkaline Phosphatase Score Correlation with Bone Marrow Blast Percentage in Myelodysplastic Syndrome
    Lipshitz, Jay
    Limaye, Sewanti
    Patel, Dilip
    ACTA HAEMATOLOGICA, 2010, 124 (03) : 179 - 181
  • [7] Cytogenetics As a Prognostic Factor Of The Overall Survival (OS) Of Mexican Patients With Myelodysplastic Syndrome (MDS)
    Rodriguez-Gonzalez, Maria Guadalupe
    Martinez-Ibarra, Yaneth
    Vela-Ojeda, Jorge
    Nacho-Vargas, Kevin
    Meillon, Luis
    Fattel, Yamile
    Robledo, Julio
    Romero-Salas, Tonatiuh
    Xolotl-Castillo, Moises
    BLOOD, 2013, 122 (21)
  • [8] Overall Survival (OS) and New Patterns of Response in Patients (Pts) With Advanced Melanoma Treated With Ipilimumab
    O'Day, Steven
    Ibrahim, Ramy
    De Pril, Veerle
    Maio, Michele
    Sileni, Vanna Chiarion
    Gajewski, Thomas F.
    Pehamberger, Hubert
    Bondarenko, Igor N.
    Queirolo, Paola
    Lundgren, Lotta
    Mikhailov, Sergey
    Roman, Laslo
    Verschraegen, Claire
    Hoos, Axel
    Humphrey, Rachel
    Wolchok, Jedd
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 937 - 938
  • [9] Retrospective Analysis of Prognostic Factors Associated With Response and Overall Survival by Baseline Marrow Blast Percentage in Patients With Myelodysplastic Syndromes Treated With Decitabine
    Jabbour, Elias
    Kantarjian, Hagop
    O'Brien, Susan
    Kadia, Tapan
    Malik, Asifa
    Welch, Mary-Alma
    Teng, Angela
    Cortes, Jorge
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (05): : 592 - 596
  • [10] Apoptosis in bone marrow of myelodysplastic syndrome patients
    Bogdanovic, AD
    Jankovic, GM
    Colovic, MD
    Trpinac, DP
    Bumbasirevic, VZ
    BLOOD, 1996, 87 (07) : 3064 - 3064
12345